The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An updated overall survival analysis with correction for protocol-planned crossover of the international, phase III, randomized, placebo-controlled trial of regorafenib in advanced gastrointestinal stromal tumors after failure of imatinib and sunitinib (GRID).
 
George D. Demetri
Stock and Other Ownership Interests - Blueprint Medicines; Caris Life Sciences; G1 Therapeutics; Kolltan Pharmaceuticals
Consulting or Advisory Role - ARIAD; AstraZeneca; Bayer; Blueprint Medicines; Caris Life Sciences; G1 Therapeutics; GlaxoSmithKline; Kolltan Pharmaceuticals; Novartis; Pfizer; Sanofi; WIRB-Copernicus Group
Research Funding - Bayer; GlaxoSmithKline; Novartis; Pfizer; Sanofi
Patents, Royalties, Other Intellectual Property - Novartis (Inst)
 
Peter Reichardt
Consulting or Advisory Role - Bayer; Novartis; Pfizer
Speakers' Bureau - Bayer; Novartis; Pfizer
Research Funding - Novartis
 
Yoon-Koo Kang
Honoraria - Bayer
Consulting or Advisory Role - Bayer
Research Funding - Bayer
 
Jean-Yves Blay
Honoraria - Bayer; Novartis; Pfizer; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Novartis; Pfizer; PharmaMar; Roche
Research Funding - Bayer; Novartis; PharmaMar; Roche
 
Heikki Joensuu
Stock and Other Ownership Interests - Orion
Consulting or Advisory Role - Blueprint Medicines
 
Klaus Bernd Schaefer
Employment - Bayer
 
Iris Kuss
Employment - Bayer
 
Christian Kappeler
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Paolo Giovanni Casali
Honoraria - Novartis; Pfizer
Consulting or Advisory Role - ARIAD; Bayer; Novartis; Pfizer
Speakers' Bureau - Novartis; Pfizer
Research Funding - Bayer; Novartis; Pfizer